(TheNewswire)
Ashkelon, Israel and Vancouver,B C - TheNewswire - January 16,2023 - BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN ) (CSE: BYND ) (“ BYNDCannasoft ” or the “ Company ”) announcedtoday that it has changed its auditor from BF Borgers CPA PC(“Former Auditor”) to Reliant CPA PC (“Successor Auditor”).
The Former Auditor resigned as auditor of the Companyeffective January 16, 2023 and the board of directors of the Companyappointed the Successor Auditor as the Company’s auditor effectiveJanuary 16, 2023, until the next annual shareholder meeting of theCompany.
There were no reservations in the Former Auditor's reports on any ofthe Company's audited financial statements and no reportable eventsbetween the Company and the Former Auditor.
In accordance with National Instrument 51-102 , the notice of changeof auditor, together with the required letters from the former auditorand the successor auditor, have been reviewed by the audit committeeand the board of directors and have been filed on SEDAR.
About BYND Cannasoft Enterprises Inc.
BYND is an Israeli-based integrated software andcannabis company.
CRM Software
BYND owns and markets a proprietary customerrelationship management (CRM) software product, known as “BenefitCRM”. BYND’s Benefit CRM software enables small and medium?sizedbusinesses to optimize their day?to?day business activities suchas sales management, personnel management, marketing, call centeractivities and asset management. BYND’s next-generation Benefit CRMplatform is now ready for BETA testing.
Cannabis CRM
Building on its 20 years of experience in CRM software,BYND has recently begun development of an innovative new CRM platform,designed specifically to serve the needs of the medical cannabisindustry. This new platform will be the first of its kind for themedical cannabis field and the Company is confident it will transformthe industry into a more organized, accessible and price transparentmarket. Data and information collected through the operation of theCannabis Farm (see below) and the products it produces will allow BYNDto test its new Cannabis CRM platform and adjust the platform asnecessary. Additionally, operating the Cannabis Farm and sellingmedical cannabis will bring in additional revenue to further supportBYND during the initial roll-out years of its cannabis CRMplatform.
Medical Cannabis Business
BYND holds an initial approval from the MedicalCannabis Unit in the Ministry of Health of the State of Israel, for acontactless business license that allows trading in medical cannabisproducts without contact with the actual substance. This is a uniquelicense that is held by only a limited number of companies in Israel.The Company is in the final stages of obtaining the full license andimmediately after receiving it, the Company plans to operate through alicensed medical cannabis farm for the production of the Company'sprivate label for various products and varieties. The products will beproduced for the Company and marketed to the pharmacies while paying acommission to the grower for the cultivation and processing of thesubstance. The Company anticipates that if the license is received inthe coming months, it will be possible to market the productsimmediately and capture a significant market share which can generatesignificant income for the Company.
For Further Information please refer to information available on the Company’swebsite: www.cannasoft-crm.com , theCSE’s website: www.thecse.com/en/listings/life-sciences/bynd-cannasoft-enterprises-inc and on SEDAR: www.sedar.com .
Gabi Kabazo
Chief Financial Officer
Tel: (604) 833-6820
e?mail: ir@cannasoft-crm.com
For Media and Investor Relations, pleasecontact:
David L. Kugelman
(866) 692-6847 Toll Free - U.S. & Canada
(404) 281-8556 Mobile and WhatsApp
Skype: kugsusa
Cautionary Note RegardingForward-Looking Statements
This press release contains forward?lookingstatements that involve risks and uncertainties, which may causeactual results to differ materially from the statements made. Whenused in this document, the words “may”, “would”, “could”,“will”, “intend”, “plan”, “anticipate”, “believe”,“estimate”, “expect” and similar expressions are intended toidentify forward?looking statements. Forward-looking statements inthis press release reflect the Company’s current views with respectto future events and are subject to such risks and uncertainties. Manyfactors could cause actual results to differ materially from thestatements made, including unanticipated regulatory requests anddelays, final patents approval and those factors discussed in filingsmade by the Company with the Canadian securities regulatoryauthorities, including (without limitation) in the Company’smanagement’s discussion and analysis for the nine month period endedSeptember 30, 2022 and annual information form dated October 8, 2022,which are available under the Company’s profile at www.sedar.com , and infilings made with the U.S. Securities and Exchange Commission. Shouldone or more of these factors occur or should assumptions underlyingthe forward-looking statements prove incorrect, actual results mayvary materially from those described herein as intended, planned,anticipated, or expected. BYND Cannasoft does not intend, and does notassume any obligation, to update these forward?looking statements,except as required by law. Shareholders are cautioned not to put unduereliance on such forward?looking statements.
Copyright (c) 2023 TheNewswire - All rights reserved.